Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic Reprogramming
Titel:
Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic Reprogramming
Auteur:
Wang, Huan Sheehan, Robert P. Palmer, Adam C. Everley, Robert A. Boswell, Sarah A. Ron-Harel, Noga Ringel, Alison E. Holton, Kristina M. Jacobson, Connor A. Erickson, Alison R. Maliszewski, Laura Haigis, Marcia C. Sorger, Peter K.